Icatibant Acetate Suppliers & Bulk Manufacturers
Available Forms: injection (prefilled syringe)
Available Strengths: 10 mg/mL
Reference Brands: Firazyr (USA/EU)
Category:
Critical Care
Icatibant Acetate is a selective bradykinin B2 receptor antagonist used for the acute treatment of hereditary angioedema (HAE) attacks. By blocking bradykinin, it rapidly reduces swelling in subcutaneous tissues, airway, and gastrointestinal tract, helping to prevent life-threatening complications associated with HAE. The drug is administered via subcutaneous injection and is suitable for emergency intervention in critical care scenarios.
Icatibant Acetate is available in injection (prefilled syringe)
and strengths such as 10 mg/mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Icatibant Acetate is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Icatibant Acetate can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing